Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
December 19 2022 - 6:26PM
ValueWalk
Supply shortages have complicated the pharmaceutical industry. Eli
Lilly & Co are making the right pivots. New partnerships aimed
at new products show great promise. The dividend is healthy, and
long-term growth looks good. 5 stocks we like better than Eli Lilly
and Heading into the week before Christmas, the United States Food
and Drug […]
https://www.valuewalk.com/eli-lilly-expects-enduring-growth-despite-immediate-challenges/
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Aug 2024 to Sep 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Sep 2023 to Sep 2024